This article provides a comprehensive framework for assessing the concordance between DNA methylation classes and genetic alterations, a critical endeavor for validating epigenetic biomarkers and understanding disease mechanisms.
This article provides a detailed analysis of the accuracy evaluation for DNA methylation-based tumor classification, a transformative tool in molecular pathology.
The transition from the GRCh38/hg38 reference genome to the complete, telomere-to-telomere T2T-CHM13 assembly represents a paradigm shift for epigenomics.
This article provides a comprehensive analysis for researchers and drug development professionals on the paradigm shift in tumor diagnostics from traditional histology to DNA methylation-based classification systems.
This article provides a comprehensive, evidence-based guide for researchers and drug development professionals on evaluating and selecting epigenomic analysis tools.
The integration of multi-omics data through clustering is pivotal for uncovering molecular subtypes in complex diseases like cancer, yet the absence of a gold standard makes method evaluation and selection...
The explosion of large-scale epigenomic data from consortia like ENCODE, Roadmap Epigenomics, and IHEC presents immense opportunities and computational challenges for researchers and drug developers[citation:1].
This article provides a comprehensive, practical guide for biomedical researchers on selecting between two prominent multi-omics integration tools: the statistical framework MOFA+ and the deep learning-based MOGCN.
This article provides a comprehensive guide for researchers, scientists, and drug development professionals on validating epigenomic findings through transcriptomic data integration.
This article provides a comprehensive comparative analysis of statistical and deep learning methodologies for multi-omics data integration, tailored for researchers, scientists, and drug development professionals.